相关实验视频
Updated: Feb 15, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
随机的第三阶段研究,将帕克利塔塞尔添加到皮细胞门癌中用凯普西塔和米托米辛C进行的化学放射治疗中
Sergey S Gordeyev1, Marina V Chernykh2, Mikhail Yu Fedyanin3
1Department of Abdominal Oncology, No. 3 of N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Tyumen State Medical University, Moscow, Russia; Sechenov First Moscow State Medical University, Moscow, Russia.
将帕克利塔塞尔添加到用capecitabine和mitomycin C进行的化学放射治疗中,改善了SCAC患者的无进展生存率和反应率,但增加了毒性. 这一发现表明了门晚期状细胞癌的潜在新治疗选择.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 胃肠道癌症 胃肠道癌症
背景情况:
- 试点研究表明,将帕克利塔塞尔添加到化学辐射疗法 (CRT) 与卡佩奇他和米托米辛C (MMC) 的治疗中,对门状细胞癌 (SCAC) 显示出有希望的疗效.
- 需要进行进一步的调查,以在随机临床试验环境中证实这些发现,并评估对无进展生存期 (PFS) 的影响.
研究的目的:
- 为了确定是否添加帕克利塔塞尔标准CRT (capecitabine和MMC) 改善PFS在I-IIIBSCAC.阶段的患者.
- 评估二次终点,包括毒性,整体存活率 (OS) 和完整临床响应 (cCR) 率.
主要方法:
- 在两个中心进行的一项随机的III期试验招募了I-IIIBSCAC.阶段的患者.
- 患者被随机分配 (1:1) 接受CRT与capecitabine和MMC (CRT-CM臂) 或CRT与capecitabine,MMC和paclitaxel (CRT-CMP臂).
- 该CRT-CMP疗程涉及IMRT,帕克利塔塞尔,卡佩西塔和MMC;主要终点是PFS.
主要成果:
- 该试验招募了87名CRT-CMP手臂的患者和86名CRT-CM手臂的患者,由于MMC无法使用,该试验于提前关闭.
- 三年PFS在CRT-CMP手臂 (84.8%) 与CRT-CM手臂 (66.9%) 相比显著更高 (P = .009).
- CRT-CMP手臂在26周后显示出更高的cCR率 (89.5%对75.9%,P=0.024),但也显著增加了3级或更严重的不良事件 (51.7%对23.3%,P<.0001).
结论:
- 将帕克利塔塞尔添加到CRT与capecitabine和MMC一起,可显著改善SCAC中的PFS和cCR率.
- 与标准CRT相比,这种组合疗法导致毒性更高.
- 这些发现表明,帕克利塔塞尔增强的CRT是SCAC的可行选择,平衡了改善的结果与增加的副作用.
相关概念视频
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Psychosexual Stages of Personality: Anal
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Random Error

